6533b85cfe1ef96bd12bd65b
RESEARCH PRODUCT
Why continued lipoprotein apheresis is vital for homozygous familial hypercholesterolemia patients with COVID-19
Reinhard KlingelFrederick J. RaalPetri T. KovanenAlpo Vuoriosubject
2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)LipoproteinsEndocrinology Diabetes and MetabolismSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Familial hypercholesterolemia030204 cardiovascular system & hematologyHyperlipoproteinemia Type II03 medical and health sciences0302 clinical medicinePandemicInternal MedicinemedicineHumansHyperlipoproteinemia Type IILife StylePandemicsLetter to the Editor030304 developmental biology0303 health sciencesNutrition and DieteticsSARS-CoV-2Life stylebusiness.industryHomozygoteCOVID-19medicine.diseaseImmunologyBlood Component RemovalCardiology and Cardiovascular MedicinebusinessLipoprotein apheresisyear | journal | country | edition | language |
---|---|---|---|---|
2021-03-01 | Journal of Clinical Lipidology |